Related Experiment Video
Updated: Mar 14, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Prevalence of Vitamin D Deficiency in Pulmonary Tuberculosis: A Prospective Cross-sectional Study
1Specialist Medicine, KIMSHEALTH, Anayara, Thiruvananthapuram, Kerala, India, Corresponding Author.
Objective:
The current cross-sectional study examined the extent of vitamin D (Vit-D) deficiency among pulmonary tuberculosis (TB)-affected patients and explored the potential associations of demographic factors with Vit-D status.
Methodology:
Conducted from 1st August 2014, to 1st February 2016, at a tertiary care center, the study included patients aged 18-60 years. Ethical approval was obtained, and exclusion criteria such as category II or multidrug-resistant TB, secondary immunodeficiency states, and extrapulmonary TB were applied. Clinical and laboratory data, including Vit-D levels, were collected. Statistical studies employed ANOVA, Chi-squared tests, and one-sample t-tests.
Results:
Among the 72 patients with TB, the majority were aged 50 years and above, with male preponderance (62%). Fifty-two (75%) TB patients had Vit-D deficiency, with an average Vit-D level of 16.68 ng/mL. The prevalence of Vit-D deficiency was significantly higher in women compared to men (92.6 vs 64.4%; p = 0.026). All patients with bilateral lung lesions had Vit-D deficiency compared to 59.3% in unilateral lung lesion patients (p = 0.002). Sputum microscopy and culture contributed to 65.28% of TB diagnoses. Vit-D deficiency prevalence was 75%, with an average Vit-D level of 16.68 ng/mL.
Conclusion:
The study highlights gender- and lesion-associated vulnerabilities to Vit-D deficiency among pulmonary tuberculosis patients. Despite limitations, the findings suggest the need for Vit-D screening in TB care and further clinical trials to explore the role of Vit-D levels in management.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

